Price target
32.500.000.00%
The 4 analysts offering 1 year price forecasts for SPRY have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to SPRY in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
SPRY EPS for the last quarter is −0.20 USD despite the estimation of −0.14 USD. In the next quarter EPS is expected to reach −0.14 USD. Track more of ARS Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter ARS Pharmaceuticals, Inc. revenue is expected to reach 15.38 M USD. Check out ARS Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, SPRY price target is 32.50 USD with a max estimate of 40.00 USD and a min estimate of 27.00 USD. Check if this forecast comes true in a year, meanwhile watch ARS Pharmaceuticals, Inc. stock price chart and keep track of the current situation with SPRY news and stock market news.
We've gathered opinions of 5 analysts rating SPRY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.